Hubei Jumpcan Pharmaceutical Co Ltd Net Asset Quality Index

Latest as of June 2026: 81.2%

Hubei Jumpcan Pharmaceutical Co Ltd net asset quality index. Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Net Asset Quality Index of 81.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥17.01 Billion minus total liabilities of CN¥3.19 Billion yields net assets of CN¥13.82 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is Hubei Jumpcan Pharmaceutical Co Ltd's book value for net asset value and shareholders' equity analysis.

Quality Index

81.2%
Equity / Total Assets

Net Assets

CN¥13.82 Billion
CNY

Total Assets

CN¥17.01 Billion
CNY

Total Liabilities

CN¥3.19 Billion
CNY

Net Asset Quality Index of Hubei Jumpcan Pharmaceutical Co Ltd (1998–2025)

Net asset quality index of Hubei Jumpcan Pharmaceutical Co Ltd from 1998 to 2025. This chart shows how Hubei Jumpcan Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of June 2026, the index stands at 81.2%, representing net assets of CN¥13.82 Billion against total assets of CN¥17.01 Billion CNY. Check how strategically is Hubei Jumpcan Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Hubei Jumpcan Pharmaceutical Co Ltd Net Asset Quality Index by Year (1998–2025)

Hubei Jumpcan Pharmaceutical Co Ltd net asset quality index by year from 1998 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hubei Jumpcan Pharmaceutical Co Ltd from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Hubei Jumpcan Pharmaceutical Co Ltd worth.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 82.7% CN¥14.63 Billion CN¥17.70 Billion CN¥3.07 Billion ▲ +2.9 pp
2024 79.8% CN¥14.73 Billion CN¥18.46 Billion CN¥3.73 Billion ▲ +6.1 pp
2023 73.7% CN¥13.37 Billion CN¥18.14 Billion CN¥4.77 Billion ▼ -2.1 pp
2022 75.8% CN¥11.35 Billion CN¥14.98 Billion CN¥3.63 Billion ▲ +0.5 pp
2021 75.3% CN¥9.13 Billion CN¥12.13 Billion CN¥3.00 Billion ▲ +1.4 pp
2020 73.8% CN¥7.76 Billion CN¥10.52 Billion CN¥2.75 Billion ▲ +3.4 pp
2019 70.5% CN¥6.10 Billion CN¥8.66 Billion CN¥2.56 Billion ▲ +0.5 pp
2018 70.0% CN¥5.46 Billion CN¥7.80 Billion CN¥2.34 Billion ▲ +3.9 pp
2017 66.1% CN¥4.40 Billion CN¥6.66 Billion CN¥2.26 Billion ▼ -7.9 pp
2016 73.9% CN¥3.69 Billion CN¥4.99 Billion CN¥1.30 Billion ▼ -1.7 pp
2015 75.7% CN¥2.71 Billion CN¥3.59 Billion CN¥872.59 Million ▲ +7.3 pp
2014 68.3% CN¥2.29 Billion CN¥3.36 Billion CN¥1.06 Billion ▲ +11.1 pp
2013 57.2% CN¥1.15 Billion CN¥2.01 Billion CN¥862.04 Million ▲ +7.8 pp
2012 49.4% CN¥490.80 Million CN¥992.87 Million CN¥502.07 Million ▼ -5.3 pp
2011 54.8% CN¥526.82 Million CN¥961.82 Million CN¥435.00 Million ▼ -5.5 pp
2010 60.3% CN¥520.27 Million CN¥863.16 Million CN¥342.89 Million ▼ -1.1 pp
2009 61.3% CN¥512.85 Million CN¥836.22 Million CN¥323.37 Million ▲ +0.3 pp
2008 61.0% CN¥506.18 Million CN¥829.61 Million CN¥323.43 Million ▼ -1.2 pp
2007 62.2% CN¥498.83 Million CN¥802.32 Million CN¥303.49 Million ▲ +0.4 pp
2006 61.8% CN¥485.82 Million CN¥786.51 Million CN¥300.69 Million ▼ -3.8 pp
2005 65.6% CN¥480.25 Million CN¥732.21 Million CN¥251.96 Million ▼ -2.3 pp
2004 67.9% CN¥473.92 Million CN¥697.90 Million CN¥223.98 Million ▼ -3.8 pp
2003 71.7% CN¥466.47 Million CN¥650.39 Million CN¥183.92 Million ▼ -3.9 pp
2002 75.6% CN¥459.05 Million CN¥607.22 Million CN¥148.17 Million ▼ -1.6 pp
2001 77.2% CN¥449.57 Million CN¥582.65 Million CN¥133.08 Million ▲ +14.5 pp
2000 62.7% CN¥140.01 Million CN¥223.38 Million CN¥83.37 Million ▼ -1.1 pp
1999 63.8% CN¥125.46 Million CN¥196.69 Million CN¥71.23 Million ▲ +5.6 pp
1998 58.2% CN¥108.44 Million CN¥186.23 Million CN¥77.79 Million —
pp = percentage points